A Study to Assess the Pharmacokinetics (uptake of drugs by the body), Safety and Tolerability of AZD4831 in Participants with Severe Renal Impairment and Healthy Volunteers

Trial Identifier: D6580C00009
Sponsor: AstraZeneca
NCTID:: NCT04949438
Start Date: January 2022
Primary Completion Date: March 2022
Study Completion Date: March 2022
Condition: Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Bulgarian Translation

Trial Locations

Country Location
BG Sofia, BG, 1612